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Abstract—Recent studies on decellularized tissue engineered
heart valves (DTEHVs) showed rapid host cell repopulation
and increased valvular insufﬁciency developing over time,
associated with leaﬂet shortening. A possible explanation for
this result was found using computational simulations, which
revealed radial leaﬂet compression in the original valvular
geometry when subjected to physiological pressure condi-
tions. Therefore, an improved geometry was suggested to
enable radial leaﬂet extension to counteract for host cell
mediated retraction. In this study, we propose a solution to
impose this new geometry by using a constraining bioreactor
insert during culture. Human cell based DTEHVs (n = 5)
were produced as such, resulting in an enlarged coaptation
area and profound belly curvature. Extracellular matrix was
homogeneously distributed, with circumferential collagen
alignment in the coaptation region and global tissue
anisotropy. Based on in vitro functionality experiments, these
DTEHVs showed competent hydrodynamic functionality
under physiological pulmonary conditions and were fatigue
resistant, with stable functionality up to 16 weeks in vivo
simulation. Based on implemented mechanical data, our
computational models revealed a considerable decrease in
radial tissue compression with the obtained geometrical
adjustments. Therefore, these improved DTEHV are
expected to be less prone to host cell mediated leaﬂet
retraction and will remain competent after implantation.
Keywords—Heart valve replacement, Tissue engineering,
Computational modeling, Decellularization, Bioreactor.
INTRODUCTION
Annually, approximately 280.000 patients world-
wide undergo either a mechanical- or bio-prosthetic
heart valve transplantation.20 Although these are life
saving devices, the lack of growth potential of these
prostheses is a major problem for pediatric patients.
They have to go through multiple staged interventions
to accommodate the increased annulus size, with
increasing morbidity and mortality risks.22 Therefore,
there is an urgent need for heart valve prostheses with
growth capacity that last a lifetime.3,21
Decellularized tissue-engineered heart valves
(DTEHVs) might represent a promising alternative.
From our ﬁrst long-term in vivo experiments, where we
implanted DTEHVs in sheep and non-human pri-
mates, we learned that the DTEHVs start to repopu-
late after 5 h, accompanied by changes in the
extracellular matrix after 8 weeks of implantation.
Moreover, there was ECM production over time,
indicative for tissue regeneration and growth poten-
tial.6,30 This in contrast to decellularized xenogeneic
heart valves, which only show limited host cell
repopulation.7,13 Besides, these DTEHVs could be
available off-the-shelf.5 Although these results are
promising, there were signs of leaﬂet shortening and
fusion of the leaﬂets with the wall, ultimately resulting
in valvular insufﬁciency, an effect which is also
reported by other groups.8,10 An explanation for this
leaﬂet-fusing and shortening problem might be found
in the valve geometry. It was shown from computa-
tional simulations by Loerakker et al.15 that the leaﬂets
in this original valve design were subjected to tissue
compression in radial direction when loaded under
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physiological pulmonary pressures. It might explain
why this particular valve geometry, in combination
with inﬁltrated host cell induced remodeling, eventu-
ally resulted into reduced leaﬂet size. Based on these
ﬁndings, Loerakker et al. also suggested an improved
valve geometry that should enable radial leaﬂet
extension during hemodynamic loading to counteract
for cellular retraction forces. This required a more
profound belly curvature, enhanced coaptation area
and predominantly circumferential collagen orienta-
tion.15 However, controlling the geometry of tissue
engineered heart valves (TEHVs) during culture was
limited thus far. Regardless of the initial shape of the
scaffold starter matrix, tissue compaction occurred in
all possible unconstrained directions in response to the
traction forces exerted by the vascular derived cells
(myoﬁbroblasts) used to culture the valves.29 This
resulted in a ﬂattened leaﬂet conﬁguration, and
absence of coaptation area after culture.12,17
Therefore, the aim of this study is to ﬁnd a solution
to be able to improve, impose and maintain the
DTEHV geometry, in accordance with the suggested
geometry from the computational simulations, to
reduce leaﬂet tissue compression in radial direction
under pulmonary loading conditions. A bioreactor
insert matching the improved geometry was developed,
which will function as an overall geometric constraint
during culture. In this way, the leaﬂets will compact
themselves around the bioreactor insert, and when
removing the insert after the decellularization proce-
dure, the DTEHV is likely to maintain its shape. This
makes it possible to design, impose and maintain the
desired DTEHV geometry. Human cell-based
DTEHVs were produced, and their functionality and
stability were assessed using hydrodynamic and fatigue
in vitro tests. The effects of the bioreactor insert on
tissue formation and collagen orientation were inves-
tigated using histology and confocal microscopy.
Furthermore, the mechanical properties were analyzed
to investigate the degree of tissue anisotropy and used
as input for computational simulations on leaﬂet tissue
loading behavior, in order to analyze the radial strain
distribution in the newly designed DTEHV.
MATERIALS AND METHODS
Insert Manufacturing and Positioning
Based on the mathematical description of Hamid
et al.11 the original valve design was improved by
adding coaptation and increasing the curvature in the
belly region as being previously described by Loer-
akker et al.15 This improved geometry was exported as
a STEP ﬁle from the simulation software (Abaqus 6.10
Simulia, USA) and imported into computer-aided de-
sign software (Autodesk Inventor, USA), to make a
one-piece component of 27.8 mm in length and
29.7 mm in diameter, which was compatible with the
diastolic pulse duplicator (DPD) bioreactor system.17
The bioreactor inserts were made out of a solid piece of
polyether ether ketone (PEEK) by using computer
controlled milling technology.
The insert was positioned at the arterial side of the
valve to enable tissue compaction around the individ-
ual posts. Small holes (0.5 mm in diameter and 1 mm
spacing) are covering the insert wall to facilitate
nutrient exchange with the adjacent tissue. Three large
triangular shaped openings on top were incorporated
for medium exchange towards the tissue-engineered
valvular wall.
Heart Valve Tissue Engineering
Tissue-engineered heart valves (TEHVs) (n = 5)
were cultured as previously described.17 In short, tri-
leaﬂet heart valves were cut from non-woven polygly-
colic-acid meshes (PGA; thickness 1.0 mm; speciﬁc
gravity 70 mg/cm3; Cellon, Luxembourg), sewn (Pro-
lene 6-0, Ethicon, USA) into a radially self expandable
nitinol stent (length = 31 mm, ID = 30 mm at 37 C;
PFM-AG, Germany), and coated with 1% poly-4-
hydroxybutyrate (P4HB; MW: 1 9 106; TEPHA Inc.,
USA) in tetrahydrofuran (THF; Sigma-Aldrich, USA).
The heart valve shaped constructs had an initial
coaptation length of 5 mm and a maximal radial belly
length of 19 mm. These constructs were sterilized with
70% ethanol (EtOH, VWR international S.A.S. Fon-
tenay-Sous-Bois, France) for 15 min, washed 3 times
with phosphate buffered saline (PBS) for 10 min,
incubated in an antibacterial-anti fungus solution 10%
penicillin/streptomycin (Pen/Strep) (Lonza, Belgium),
with 0.5% fungin (InvivoGen, USA), for 30 min, and
washed 3 times with PBS for 10 min. Hereafter, the
valves were incubated overnight in growth medium
(Advanced Dulbecco’s Modiﬁed Eagle Medium, Gib-
co, USA), supplemented with 10% fetal bovine serum
(FBS, Biochrom, Germany), 1% Pen/Strep and 1%
Glutamax (Gibco, USA). Primary isolated human
vascular-derived cells were harvested from the human
vena saphena magna from a 77-year-old patient,
according to the Dutch guidelines for secondary used
materials, and seeded (0.3 9 106 cells/cm2, passage 6)
into the valvular shaped scaffolds using ﬁbrin as a cell
carrier. The seeded constructs were placed into theDPD
bioreactor system together with the newly developed
insert, containing growth medium supplemented with
L-ascorbic acid 2-phosphate (0.25 mg/mL, Sigma,
USA). Pulsatile ﬂow was applied at 1 Hz to the un-
shielded ventricular side of the valve.
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Decellularization Procedure
After 4 weeks of culture, the obtained TEHVs
(n = 5) were decellularized as described by Dijkman
et al.5 Brieﬂy, TEHVs were washed 3 times 10 min with
PBS and decellularized overnight in detergent solution
(0.25% Triton X-100, sodium deoxycholate and 0.02%
EDTA), where after the bioreactor insert was removed.
Nucleic remnants were enzymatically degraded by using
Benzonase (EMD Millipore, USA) incubation steps,
diluted in 50 mM TRIS–HCL buffer solution in con-
centrations of 100, 80 and 20 U/mL for 8, 16 and 8 h,
respectively, on a shaker at 37 C. Afterwards, the
DTEHVs were washed 3 times with PBS and incubated
for 24 h inM-199 medium (Gibco, USA) on a shaker at
4 C to remove cellular remnants. Valves were washed 3
times with PBS, sterilized with 70% EtOH for 15 min,
washed 3 timeswith PBS, and incubated for 30 minwith
an anti-fungi/bacterial solution. After sterilization, the
DTEHVs were stored at 4 C until further use.
In-Vitro Valve Functionality
Out of the 5 DTEHVs, 4 were used for in vitro valve
functionality assessments, and the remaining valve
served as a control, not subjected to fatigue testing.
Hydrodynamic Pulsatile Functionality Assessment
DTEHVs (n = 4)were placed inside a silicon annulus
of 30 mm inner diameter and positioned into a hydro-
dynamic pulsatile test system (HDT-500, BDC Labo-
ratories, USA) containing a physiologic saline solution
at 37 C. Valves were subjected to physiological pul-
monary conditions (rate of 72 BPM, stroke of 70 mL,
maximumdiastolic pressure difference of 25 mmHg) for
1 h.Flowandpressuresweremeasured using a transonic
sensor (TS410, Transonic Systems, USA) and pressure
sensors (BDC-PT, BDC Laboratories, USA), respec-
tively. Data was collected for 3 s at 5 kHz, and func-
tionality was assessed from an average over 10 cardiac
cycles by using StatysTM software (BDC Laboratories,
USA), to determine the regurgitation fraction, the
effective oriﬁce area (EOA), and cardiac output (CO).
The regurgitation fraction was deﬁned as being the sum
of the leakage volume and the closing volume, expressed
as a percentage of the stroke volume. Slow-motion
movieswere recorded at high-speed burstmode to assess
opening and closing behavior of the valves in motion
(G15 PowerShot, Canon, USA).
Fatigue Assessment
DTEHVs (n = 4) were placed inside a 30 mm
diameter silicon annulus and positioned into a valve
durability tester (VDT-3600i, BDC Laboratories,
USA) containing physiologic saline solution at 37 C.
Valves were subjected to accelerated opening and
closing cycles at a frequency of 10 Hz and a stroke
between 1.20 and 2.10 mL. Proper opening and closing
behavior was assessed by analyzing slow-motion
recordings (G15 PowerShot, Canon, USA). During
closure, the maximum differential loading was targeted
at 28 mmHg and was automatically maintained. After
each 3 9 106 cycles, the DTEHVs were tested again for
their hydrodynamic functionality by using the hydro-
dynamic pulsatile test system as described above.
Qualitative Tissue Analysis and Global Collagen
Orientation
Histology
Middle sections of the valves (n = 5) were ﬁxed
overnight in 3.7% formalin (Fluka, USA) at 4 C. After
washing in PBS, the samples were embedded in Tissue-
Tek (Sakura, the Netherlands) and cured gradually in
liquid nitrogen vapor. Cryosections were cut at 10 lm
thickness and stained for Hematoxylin and Eosin
(H&E) to assess general tissue formation and the effec-
tiveness of the decellularization procedure, Masson
Trichrome (MTC) (Staining kit, Sigma, USA) for the
presence and distribution of collagen, and Elastica van
Gieson (EvG) (Staining kit, Merck, Germany) for the
presence of elastic matrix formation. The samples were
embedded in Entellan (Merck, Germany) and analyzed
using bright ﬁeld microscopy (Axio Observer Z1, Zeiss,
Germany) in the mid regions of the heart valve leaﬂets.
Confocal Microscopy
Half leaﬂet sections of all (n = 5) valveswere analyzed
for the effect of the insert on the global collagen orien-
tation. Samples were stained using a whole mount stain-
ing with the collagen speciﬁc dye CNA35-OG488,14 for
1 h in PBS and visualized with a confocal microscope
(TCS SP5X, Leica, Germany). The dye has an excitation
and emissionproﬁle of 488 and500–550 nm, respectively.
Samples immerged in Mowiol (Sigma, USA) were
mounted between two preparation glasses. The specimen
was observed with a 910 objective and Z-stacks were
made throughout 200 lmof the entire arterial side of the
sample using stitched adjacent tile scans. Afterwards, a
maximum intensity projection was made in Z-direction.
Tissue Mechanics and In Vivo Collagen Remodeling
Simulations
Biomechanical Analyzes
Mechanical properties of the control valve were
analyzed by using a biaxial tensile tester (BioTester,
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5 N load cell; CellScale, Waterloo, Canada) in com-
bination with LabJoy software (V8.01, CellScale). Two
square samples (36 mm2 each) per valve were sym-
metrically cut from the belly region. Sample thickness
was measured at 3 random locations using an elec-
tronic caliper (CD-15CPX, Mitutoyo, Japan) and
averaged. The samples were stretched equibiaxially in
both the radial and circumferential direction up to
20% strain, at a strain rate of 100% per minute. After
stretching, the samples recovered to 0% strain at a
strain rate of 100% per minute, followed by a rest cycle
of 54 s. Prior to measuring the ﬁnal stresses, samples
were preconditioned with 5 of these cycles. A high-
order polynomial curve was ﬁtted through each indi-
vidual data set in both the radial and circumferential
direction. The stiffness of the tissue was represented by
the tangent modulus and was deﬁned as the tangent to
the ﬁtted polynomial curve at 20% strain.
Computational Simulations
Based on the obtained experimental mechanical
data of these improved DTEHVs, computational
simulations (Abaqus 6.10 Simulia, USA) as described
by Loerakker et al.15 were executed to examine if the
implemented changes in valve geometry resulted in
reduced radial compression under pulmonary pressure
conditions. The original valve design was based on the
mathematical description of Thubrikar27 with the
parameters Rb = Rc = 13.5 mm, H = 19.15 mm,
Hs = 3.15 mm and b = 0 without any coaptation.
The improved valve geometry was described by Hamid
et al.11 with the parameters a = b = 3.1 mm,
H = 18 mm, R = 13.5 mm, with 5 mm coaptation.
All values were obtained as described in the original
paper15 and both designs used the experimentally
measured tissue thickness of 0.58 mm.
The total stress in the tissue was given by the stress
in the collagen ﬁbers (with volume fraction /f) and the
isotropic matrix components (with volume fraction
1 /fð Þ)15:
r ¼ rm þ rf ð1Þ
The isotropic matrix stress is equal to:
rm ¼ 1 /fð Þ j
ln J
J
Iþ G
J
ðB J23I
 
ð2Þ
with B = F Æ FT the left Cauchy-Green tensor, F the
deformation gradient tensor, J = det (F) the volu-
metric change ratio. The tissue was modeled as almost
incompressible (t = 0.498), and the shear modulus G
was set to 10 kPa to prevent numerical instabilities.
The compression modulus is deﬁned as:
j ¼ 2G 1þ tð Þ
3 1 2tð Þ : ð3Þ
The collagen ﬁbers were modeled with an angular
distribution of ﬁbers (resolution of 3), where the stress
if given by:
rf ¼
XN
i¼1 u
i
fr
i
f~e
i
f~e
i
f ð4Þ
with N the number of ﬁber directions, uf
i the collagen
volume fraction in direction i
PN
i¼1 u
i
f ¼ /f
 
; rif the
magnitude of the stress in each ﬁber direction, and~eif a
unit vector in the deformed ﬁber direction i. The mag-
nitude of the stress is a function of the ﬁber stretch kf:
rf ¼ k1k
2
f e
k2 k
2
f1ð Þ  1
 
for kf  1
0 for kf<1
(
ð5Þ
The collagen volume fractions are described with a
Gaussian distribution:
uif ¼ Aexp
 ci  lð Þ2
2r2
 !
ð6Þ
with ci the angle of ﬁber direction i with respect to the
circumferential direction, l the main ﬁber angle (0), r
the standard deviation, and A a scaling factor to en-
sure that
PN
i¼1 u
i
f ¼ uf. Parameters k1; k2; and r were
ﬁtted to the equibiaxial tensile test data of the control
valve according to the least squares method. The effect
of collagen anisotropy on tissue loading was investi-
gated by comparing the experimentally determined
collagen anisotropy to complete collagen isotropy.
Eventually, the computational model simulated the
radial and circumferential strains in the DTEHV
leaﬂets, by applying a mean pulmonary differential
pressure of 15 mmHg over the valve, using both the
original as well as the improved geometry.
Statistics
To analyze DTEHV fatigue behavior over time, a
linear regression analysis was performed (Prism V6.0d,
Graphpad, USA) on the closing volume, leakage vol-
ume, cardiac output, and the eﬀective oriﬁce area, with
a slope being signiﬁcantly non-zero for p< 0.05. Time
points were averaged, and represented by their
mean ± standard deviation.
For the biomechanical analysis, samples were
averaged per valve, and represented by their
mean ± standard deviation. The presence of aniso-
tropy was deﬁned as a signiﬁcant diﬀerence (p< 0.05)
between the obtained stiffnesses in both radial and
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circumferential direction, analyzed using a paired stu-
dent t test (Prism V6.0d, Graphpad, USA).
RESULTS
Production and Functionality of the Bioreactor Insert
Production of the Insert
The improved heart valve geometry as suggested by
the computational simulations, was successfully
translated into a physical rigid object (Fig. 1a),
matching the exact same geometry. The surface of the
insert was smooth and the holes were equally dis-
tributed over the entire surface to enable sufﬁcient
nutrient exchange to the scaffold. There was sufﬁcient
space between the individual posts to prevent leaﬂet
fusion during culture. The insert ﬁtted nicely into the
DPD bioreactor system without obstructing the pul-
sating ﬂow passing by the ventricular side towards the
arterial side (Fig. 1b).
Functioning of the Insert
During the 4 weeks of culturing, the leaﬂets of the
TEHVs compacted tightly around the insert, adapting
to the imposed geometry. After decellularization, the
valves maintained their shape, and there was no leaﬂet
retraction visible upon removal of the insert. The
coaptation area was approximately 5 mm in length
(Fig. 1c), and the belly region of the DTEHVs main-
tained the imposed curvature (Fig. 1d). Tissue was
uniformly distributed throughout the leaﬂets, without
any damage or other macroscopically detectable
irregularities.
Hemodynamic Functionality and Fatigue Resistance
DTEHVs (n = 4) were subjected to physiological
pulmonary conditions in a hydrodynamic test setup. A
representative graph of one valve is shown in Fig. 2.
Overall, all valves opened up completely (Figs. 2b–2d),
and closed symmetrically (Figs. 2e–2f). Prolapse was
not observed in any of the valves.
For the long-term durability assay, valve opening
and closing behavior was set to be comparable to the
physiological behavior as observed in the hydrody-
namic setup. From the DTEHVs (n = 4) subjected to
fatigue tests, three remained functional up to about 12
million cycles, representative for 16 weeks in vivo fol-
low-up time. One valve failed at 4 million cycles, and
was unable to maintain stable pressure conditions
during fatigue testing from the start. The valves
showed no decrease in functionality over time by
having an initial regurgitation fraction of
4.13 ± 1.44%, consisting out of a closing volume
percentage of 3.41 ± 1.42%, and a leakage volume
FIGURE 1. Bioreactor insert and representative DTEHV re-
sults. The developed bioreactor insert, used to impose and
control the heart valve geometry during culture (a). A sche-
matic representation of the positioning of the insert depicted
in green, inside the bioreactor setup with the heart valve
indicated in red, the nitinol stent in black and the pulsatile
medium flow as a blue arrow (b). Two representative pictures
of a human cell based DTEHVs cultivated by using the insert,
from a top (c) and bottom view (d), showing large coaptation
areas and an profound belly curvature, matching the shape of
the bioreactor insert.
FIGURE 2. Physiological hydrodynamic pulmonary in vitro
test results. Representative results of a DTEHV subjected to
in vitro hydrodynamic physiological pulmonary pulsatile
stimulation after 12 million cycles, showed competent valve
functioning as indicated in the graph (a). Valves were opening
completely (b–d) and closed symmetrically (e, f).
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percentage of only 0.73 ± 0.08% (Fig. 3a). The valves
maintained a consistent effective oriﬁce area of
2.37 ± 0.04 cm2, with a maintained cardiac output of
4.80 ± 0.11 L/min over time (Fig. 3b). Loss in func-
tionality was sudden and in all cases the result of leaﬂet
rupture at one of the commissure points.
Qualitative Tissue Analysis and Global Collagen
Orientation
Histological Appearance
Histologywas performed on samples of all DTEHVs.
Representative photographs in Fig. 4, show that the
tissue was uniformly distributed throughout the thick-
ness of the leaﬂets. Furthermore, no necrotic or dam-
aged tissue was observed. The decellularization
procedure successfully removed all cells as demon-
strated by the H&E staining, although scaffold rem-
nants were still present in the tissues (Fig. 4a). From the
MTC staining it appeared that the leaﬂets are mainly
composed of collagen (Fig. 4b), with no signs of elastic
matrix formation in theVvG staining (Fig. 4c), aswould
otherwise be indicated by black ﬁbers.
Global Collagen Orientation
By analyzing the collagen whole mount stainings,
global collagen orientation was visualized throughout
~200 lm in depth, over the entire half of 5 DTEHV
leaﬂets. A representative maximum projection in Z-di-
rection is shown in Fig. 5a. Here, the collagen was
clearly aligned in circumferential direction in the coap-
tation area (Fig. 5b) and more randomly distributed
towards the bottom region of the belly (Fig. 5c).
Tissue Mechanics and In Vivo Collagen Remodeling
Simulations
Biomechanical Properties
The averaged tensile curves from the control valve
showed Cauchy stresses ranging between 200–300 kPa
in radial direction and 300–400 kPa in circumferential
direction at 20% strain (Fig. 6a), indicative for tissue
anisotropy. From the averaged equibiaxial tensile tests
on all valves, it appeared that the tangent moduli were
signiﬁcantly higher in circumferential direction, com-
pared to the radial direction (p = 0.035), being
3.59 ± 0.95 and 2.47 ± 0.74 MPa respectively at 20%
strain (Fig. 6b).
Computational Simulations
Fitting the numerical model on the experimental
tensile data of the control group (Fig. 6b), resulted in
the following parameter values: k1 ¼ 22:0 kPa; k2 ¼
7:50; and r ¼ 67:5 :
At a mean pulmonary diﬀerential pressure of
15 mmHg the computational simulations revealed that
the original design was subjected to leaﬂet tissue
compression in the radial direction throughout the
entire leaﬂet during loading (Fig. 7a). The improved
valve design of these DTEHVs showed a considerable
decrease in radial tissue compression as compared to
the original design (Fig. 7b). Strains in the circumfer-
ential direction were maintained and comparable in
both designs. Besides, the effect of the present collagen
anisotropy on tissue loading in the improved design,
revealed no changes in radial tissue compression
compared to fully isotropic collagen orientation
(Fig. 7c).
FIGURE 3. Long-term functional behavior of DTEHVs in vitro. Interval measurements of the regurgitation fraction, cardiac output,
and effective orifice area, from start (n 5 4), after 3 million cycles (n 5 4), 6 million cycles (n 5 3), 9 million cycles (n 5 2), and after
12 million cycles (n 5 2), showing no significant increase in regurgitation over time (p< 0.05) (a). Also the cardiac output and
effective orifice area maintained stable over time (b). Values are represented as mean values 6 standard deviation.
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DISCUSSION
From our ﬁrst long-term in vivo experiments where
we implanted DTEHVs in sheep, we observed leaﬂet
fusion with the wall, which resulted in the development
of valvular insufﬁciency over time.6,30 Based on com-
putational simulations it was hypothesized that the
original DTEHV geometry had to be adjusted to en-
able leaﬂet extension in the radial direction, rather
than compression. Therefore, a bioreactor insert was
developed to impose the desired valvular geometry
during culture, which was maintained after decellu-
larization and removal of the insert. This resulted in
DTEHVs with an increased coaptation area and a
signiﬁcant radial and circumferential belly curvature.
Adjusting the culture conditions in the bioreactor
system by introducing a constraining insert might have
aﬀected tissue formation by limiting nutrient and
FIGURE 4. Histology on DTEHVs. Representative images of stained sections of DTEHV leaflets with Hematoxylin and Eosin,
showing appropriate decellularization, equal tissue formation and the presence of scaffold remnants (a). Masson Trichrome
revealed mainly collagen deposition depicted in blue (b), where Elastica van Gieson indicated no elastic matrix formation within
the construct (c).
FIGURE 5. Global collagen orientation. Representative image of a collagen specific whole mount staining on half a DTEHV leaflet,
visualized by confocal microscopy at the ventricular side (a), revealed that collagen orientation was clearly aligned in circum-
ferential direction in the coaptation area (b), and randomly distributed towards the bottom of the belly (c). Black spots indicate local
regions that were out of focal plane.
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oxygen exchange. However, it appeared that these
DTEHVs still contain a uniform ECM distribution
throughout the entire thickness of the leaﬂets, con-
sisting mainly of collagen. These histological ﬁndings
are in agreement with previously cultured human cell-
based TEHVs having the original valve geometry
without the insert.16
Further more the global collagen orientation was
inﬂuenced by introducing the insert. During tissue
culture, non-woven PGA meshes are known to hy-
drolyze, thereby losing their mechanical integrity and
structural support.9,19,23 This degradation proﬁle in
combination with the tension forces exerted by the
cells, led to tissue compaction in the unconstrained
directions, which resulted in collagen orientation along
the constrained direction.4,18
In this study, tissue compaction against a rigid ob-
ject was used to impose the DTEHV geometry
according to the shape of the bioreactor insert. After
2 weeks of culture, the scaﬀold loses its mechanical
integrity and the tissue starts to compact.29 While
compacting, the leaﬂet tissue is being constrained by
the rigid bioreactor insert, except for the tissue at the
free edges of the leaﬂets that could still compact
slightly in the radial direction. This resulted in mainly
circumferential aligned collagen in the coaptation area,
and a more random distribution towards the bottom of
the belly.
Other studies in which constraining methods were
used to control the geometry of DTEHVs are
promising, however no long-term functionality up to
12 million cycles have been reported so far.18,24–26,28
The DTEHVs created in the present study showed
satisfactory long-term functionality up to 16 weeks
in vivo simulation in terms of regurgitation, cardiac
output and opening and closing behavior, with only
one valve failing after 4 million cycles, being unable to
adapt and stabilize to the applied pulmonary pressure
conditions during fatigue testing. From previous
in vivo implantation studies in both sheep and non-
human primates, host cell repopulation was observed
within 5 h, accompanied by changes in the extracellu-
lar matrix after 8 weeks, with evidence of ECM pro-
duction by these cells.6,30 Therefore, the DTEHVs as
developed in this study are expected to be sufﬁciently
fatigue resistant under physiological pulmonary con-
ditions, to provide sufﬁcient time for host cells to
repopulate and maintain the ECM.
In addition to the improved valvular geometry in
terms of a large coaptation area and an enhanced belly
curvature, collagen anisotropy is essential to obtain
radial leaﬂet stretch during dynamic loading, charac-
teristic for native leaﬂets,2 were anisotropy is expected
to further increase after in vivo implantation because of
strain-induced collagen reorganization by the repopu-
lating host cells.4 Compared to reported stiffness val-
ues,1 human native aortic heart valve leaﬂets have a
tangent modulus in radial and circumferential direc-
tion of about 2.0 ± 1.5 and 15.6 ± 6.4 MPa respec-
tively. The reported tangent modulus of the DTEHVs
in radial direction is comparable with 2.5 ± 0.7 MPa,
but is lower in circumferential direction with 3.6 ±
1.0 MPa.
Despite that local observed diﬀerences in collagen
anisotropy were not implemented into the model, these
computational simulations revealed that the additional
FIGURE 6. Mechanical properties of the DTEHVs. The averaged stress–strain curves obtained from equal biaxial tensile tests of
the control group, in both radial and circumferential direction, shows Cauchy stresses ranging between the 200–400 kPa (a). The
fitted curves are used as material parameters for the computational simulations (a). The calculated tangent moduli of all DTEHVs
showed a significant increase in tissue stiffness in circumferential direction compared to the radial direction (*p 5 0.035) (b). All
values are represented as mean values 6 standard deviation.
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eﬀect of the overall collagen anisotropy seems not to
inﬂuence the tissue loading behavior under pulmonary
loading conditions. Therefore the implemented geo-
metrical improvements only, were already suﬃcient to
prevent radial tissue compression almost completely in
the entire valve.
The concept of using DTEHVs for human applica-
tions still holds great promise in terms of regenerative
capacity and growth potential, which would overcome
the necessity for multiple re-interventions in young
patients. The use of autologous cells is not required
and allogeneic cells can be used that simpliﬁes regula-
tions and allows for oﬀ-the-shelf availability. Further
development on biodegradable stents that are suitable
for minimal invasive heart valve implantation should
be focus of future studies to complete the growing
valve concept.
In conclusion, this study proposes a successful
solution to impose a desired three-dimensional curved
tissue engineered valvular geometry by using a con-
straining bioreactor insert during culture, which allows
for a maintained shape after decellularization and re-
moval of the insert. This resulted in fully competent
oﬀ-the-shelf available human cell-based DTEHVs with
a large coaptation area and profound belly curvature.
Long-term functionality was maintained mainly up to
FIGURE 7. Computational simulations. Material parameters of the DTEHVs were implemented into an established computational
valve model, to assess the strains in radial and circumferential direction in both the original and the improved valve design,
simulating 15 mmHg mean pulmonary pressure. In the original valve design the entire leaflet tissue is being compressed in radial
direction (a). The improved valve design showed a considerable decrease in radial compression in the belly (b), which is primarily
due to geometrical improvements rather than collagen anisotropy (c). Strains in circumferential direction are comparable between
both valve designs.
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16 weeks in vivo simulation, allowing sufﬁcient time for
host cell repopulation. Usage of the bioreactor inserts
resulted in homogeneously distributed tissue forma-
tion, circumferential collagen orientation in the coap-
tation region, and overall leaﬂet tissue anisotropy.
Based on the mechanical data, our computational
models revealed a considerable decrease in radial tissue
compression with the obtained geometrical adjust-
ments. Therefore, these improved DTEHV are ex-
pected to be less prone to host cell mediated leaﬂet
retraction and will remain competent after implanta-
tion.
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